Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Other financing activities (2016 - 2025)

Historic Other financing activities for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to -$23000.0.

  • Pediatrix Medical's Other financing activities rose 1481.48% to -$23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$75000.0, marking a year-over-year increase of 7282.61%. This contributed to the annual value of $135000.0 for FY2024, which is 10153.88% up from last year.
  • According to the latest figures from Q3 2025, Pediatrix Medical's Other financing activities is -$23000.0, which was up 1481.48% from -$34000.0 recorded in Q2 2025.
  • Pediatrix Medical's Other financing activities' 5-year high stood at $7.9 million during Q1 2022, with a 5-year trough of -$6.8 million in Q3 2023.
  • Over the past 5 years, Pediatrix Medical's median Other financing activities value was $46000.0 (recorded in 2024), while the average stood at $630473.7.
  • As far as peak fluctuations go, Pediatrix Medical's Other financing activities surged by 429259.26% in 2022, and later plummeted by 310969.16% in 2023.
  • Quarter analysis of 5 years shows Pediatrix Medical's Other financing activities stood at $7.0 million in 2021, then tumbled by 89.6% to $732000.0 in 2022, then crashed by 144.81% to -$328000.0 in 2023, then skyrocketed by 125.3% to $83000.0 in 2024, then tumbled by 127.71% to -$23000.0 in 2025.
  • Its Other financing activities stands at -$23000.0 for Q3 2025, versus -$34000.0 for Q2 2025 and -$101000.0 for Q1 2025.